Real World Patient Perceptions of the use of Tazarotene 0.1% Foam in the Treatment of Acne Vulgaris

Main Article Content

James Q Del Rosso
Corey L Hartman
Caitlin Lewis
Rhonda Schreiber


Acne Vulgaris, Acne, Tazarotene, retinoid


Abstract not available.


1. Dréno B, Thiboutot D, Gollnick H, Finlay AY, Layton A, Leyden JJ, Leutenegger E, Perez M Global Alliance to Improve Outcomes in Acne Large scale worldwide observational study of adherence with acne therapy Int J Dermatol 2010 Apr 49 4 448 56

2. Kircik LH Importance of vehicles in acne therapy J Drugs Dermatol 2011 Jun 10 6 s 17 23

3. Del Rosso JQ, Kircik LH, Zeichner J, Stein Gold L The Clinical Relevance and Therapeutic Benefit of Established Active Ingredients Incorporated into Advanced Foam Vehicles Vehicle Characteristics Can Influence and Improve Patient Outcomes J Drugs Dermatol 2019 Feb 1 18 2 s) s 100 s 107

4. Eastman WJ, Malahias S, Delconte J, DiBenedetti D Assessing attributes of topical vehicles for the treatment of acne, atopic dermatitis, and plaque psoriasis Cutis 2014 Jul 94 1 46 53

5. Smith JA, Narahari S 2 Hill D, Feldman SR Tazarotene foam, 0 1 for the treatment of acne Expert Opin Drug Saf 2016 Jan 15 1 99 103

6. Feldman SR, Werner CP, Alió Saenz AB The efficacy and tolerability of tazarotene foam, 0 1 in the treatment of acne vulgaris in 2 multicenter, randomized, vehicle controlled, double blind studies J Drugs Dermatol 2013 Apr 12 4 438 46

7. Epstein EL, Stein Gold L Safety and efficacy of tazarotene foam for the treatment of acne vulgaris Clin Cosmet Investig Dermatol 2013 May 14 6 123 5

8. Data on file, Mayne Pharma

Similar Articles

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)

1 2 3 > >>